Le Lézard
Classified in: Health
Subject: LAW

Los Angeles Weight Loss Surgery Expert, Dr. David Davtyan, Seeing Notable Increase in Patients Amidst News of Recent Medication Lawsuit


Dr. David Davtyan, a renowned expert, has experienced a surge in new patients seeking his expertise as the recent lawsuit against Ozempic/Mounjaro has further fueled the public's growing apprehension towards pharmaceutical solutions for weight loss.

LOS ANGELES, Sept. 28, 2023 /PRNewswire-PRWeb/ -- As obesity rates continue to rise globally, individuals struggling with excess weight are faced with the challenging decision of choosing the best course of action for sustainable weight loss. Many new patients have been consulting with Dr. David Davytan as reports have surfaced that could link certain types of prescription medications, such as Ozempic, to an increased risk of developing gastroparesis and other issues. This has led them to seek safer and more effective alternatives that can help combat obesity-related health issues. As a leading authority, Dr. Davytan firmly believes that weight loss surgery surpasses medication as the superior option for achieving long-term success in managing obesity and wants to draw attention to the critical advantages and proven efficacy of weight loss surgery over medication-based approaches. According to Dr. Davytan, "Weight loss surgery offers a comprehensive approach that targets the underlying factors contributing to obesity, including genetics, metabolism and behavioral patterns. Medications, on the other hand, only address symptoms without addressing the root causes. The surgical procedures I perform, such as sleeve gastrectomy and the lap-band, provide measurable and sustainable results, leading to significant weight loss and improved overall health." Dr. Davytan emphasizes that weight loss surgery not only aids in shedding excess pounds but also has a profound impact on mitigating obesity-related conditions such as type 2 diabetes and hypertension. While pharmaceutical interventions may have a necessary place in weight management, they frequently present hurdles such as potential side effects, long-term usage requirements and limited effectiveness in some cases. With a patient-centered philosophy, Dr. Davytan prioritizes personalized care at his practice, ensuring a tailored treatment plan that suits unique needs and goals.

"The increased interest in those seeking sustainable long-term weight loss solutions at my practice is truly remarkable, as patients are becoming more alarmed by the notion of a quick fix and safety questions regarding medication use for weight loss," says Dr. Davtyan.

"The increased interest in those seeking sustainable long-term weight loss solutions at my practice is truly remarkable, as patients are becoming more alarmed by the notion of a quick fix and safety questions regarding medication use for weight loss," says Dr. Davtyan.

More about Dr. David Davtyan:

Dr. David Davtyan is a highly-respected weight loss surgeon with over 28 years of experience and has treated thousands of patients with exceptional results. He earned his medical degree from UCLA's School of Medicine, where he was trained to treat extremely difficult and metastatic cancer cases. He went on to study bariatric surgery in Belgium, where the Lap-Band was first introduced, and became one of the first surgeons in the United States to offer the procedure once it achieved FDA approval in April of 2001. At the Weight Loss Surgery Center of Los Angeles, Dr. Davtyan offers expert guidance and a wide spectrum of cutting-edge endoscopic, surgical and minimally invasive weight loss procedures to provide excellent outcomes for patients. Dr. Davtyan and his team offer top-quality weight loss surgery (bariatric surgery) and treatment in Los Angeles, Orange County and the Inland Empire. For more information, please call 877-923-7546 or visit http://www.weightlosssurgeryla.com

Media Contact

Kia, Weight Loss Surgery Center of Los Angeles, 877-923-7546, [email protected], https://weightlosssurgeryla.com/ 

SOURCE Weight Loss Surgery Center of Los Angeles


These press releases may also interest you

at 05:30
Provisio Medical, Inc. today announced the formation of a Physician Advisory Board (PAB) comprising a multidisciplinary group of physicians who will provide input and feedback on product development decisions, outcome- focused clinical studies and...

at 05:00
Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential treatment for people living with diabetic macular ischemia (DMI). The study found that BI 764524 was well...

at 04:21
The revenue in April for Zinzino's sales markets increased by 34 % and amounted to SEK 155.7 (116.0) million. Faun Pharma's external sales increased by 54 % and amounted to SEK 8.0 (5.2) million. Overall, the Group increased revenues by 35 % to SEK...

at 04:00
Nearly all American adults (95%) agree stroke is an emergency, yet according to new omnibus survey by The Harris Poll on behalf of the Get Ahead of Stroke® campaign, less than half (43%) say they would call 911 if they were experiencing a common...

at 04:00
Pan-Canadian children's health advocate Children's Healthcare Canada is calling on the federal government to show political will to solve the crises plaguing children's healthcare and declare children's health and well-being a national priority. ...

at 03:44
21st.BIO unveiled a new pilot plant facility in its Danish...



News published on and distributed by: